Paul Jardine
Director/Board Member at Apertor Pharmaceuticals, Inc.
Profile
Paul Da Silva Jardine is a venture partner at ATP.
Paul spent 25 years at Pfizer Research, first as head of Cardiovascular and Metabolic Diseases (CVMD) Chemistry, then as vice president of the CVMD Biology Research Unit.
Teams under Paul’s leadership discovered and developed more than 50 clinical candidates, two of which were licensed by the FDA and EMA as human medicines, and two of which were approved as veterinary medicines.
In 2015, Paul left Pfizer to found and lead Staten Biotechnology, delivering into clinical development the only known anti-ApoC3 antibody for the treatment of coronary heart disease, which in 2018 Novo Nordisk acquired the option to buy for €430 million.
Paul was a venture partner at ATP from 2017 to 2019, during which time he created a program that was incorporated into ATP portfolio company Chinook Therapeutics (NAS: KDNY).
He then headed drug discovery efforts for Foresite Labs before returning to ATP.
Paul received a BS in chemistry from the University of Texas at Austin, and at Harvard University he earned a PhD and conducted postdoctoral research in synthetic organic chemistry in the labs of Nobel laureate chemist E.J.
Corey.
Paul Jardine active positions
Companies | Position | Start |
---|---|---|
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Private Equity Investor | 2016-12-31 |
Aethon Therapeutics, Inc.
Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that provides services available through their website. The company is based in New York, NY. The company uses cookies to enhance the user's experience and provide essential website cookies. The CEO of the company is Rajesh Chopra. | Director/Board Member | - |
Apertor Pharmaceuticals, Inc.
Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. | Director/Board Member | - |
Training of Paul Jardine
The University of Texas at Austin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
Aethon Therapeutics, Inc.
Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that provides services available through their website. The company is based in New York, NY. The company uses cookies to enhance the user's experience and provide essential website cookies. The CEO of the company is Rajesh Chopra. | Health Services |
Apertor Pharmaceuticals, Inc.
Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. | Health Technology |
- Stock Market
- Insiders
- Paul Jardine